http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2761268-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-49 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8be3ad3e212949b9a14f782dba1ec25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51590455ecdcf736b5d2310cd5c283c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11670bea6042d1e0490b82267f4d1d6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99ea99418db049ed06c6f81a6bc7c902 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d29e800d97d0cf42e7c7560d05ea822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10a9428dce35fe4bcdd833b33720489 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d77b8c765f6d7a8a7961c5e5004e44c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e72d67bbc02ea5d3908ad570c44cb0ff |
| publicationDate | 2021-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2761268-C1 |
| titleOfInvention | Method for predicting an unfavorable course of retinopathy in premature infants |
| abstract | FIELD: ophthalmology. n SUBSTANCE: invention relates to ophthalmology and can be used to identify a group of children at high risk of developing retinopathy of prematurity with an unfavorable course of the disease. For this, in premature infants with a post-conceptual age of 32-35 weeks, the serotonin content is determined in the blood plasma. When its level is equal to or below 14.0 pg/ml, the development of retinopathy of prematurity is predicted. n EFFECT: invention makes it possible to predict the risk of developing retinopathy of premature infants with an unfavorable course of the disease in order to adjust the tactics of managing such patients and to reduce the number of examinations of premature infants with a lower risk of developing this disease. n 1 cl, 1 tbl, 4 ex |
| priorityDate | 2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.